Tenascin and fibronectin expression in human mesothelial cells and pleural mesothelioma cell-line cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 19, Issue 3, 1998, Pages 445-452

  Kinnula, Vuokko L ^a   Linnala, Auli ^b   Viitala, Eija ^b   Linnainmaa, Kaija ^b   Virtanen, Ismo ^b  

^a UNIVERSITY OF OULU   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOSITE; FIBRONECTIN; HYDROGEN PEROXIDE; MESSENGER RNA; TENASCIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VITAMIN K GROUP;

ARTICLE; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG DISEASE; METABOLISM; PATHOPHYSIOLOGY; PLEURA TUMOR;

ASBESTOS, AMOSITE; FIBRONECTINS; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; LUNG DISEASES; PLEURAL NEOPLASMS; RNA, MESSENGER; TENASCIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN K;

EID: 0032161342     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.19.3.2884     Document Type: Article

References (50)

1. Chiquet-Ehrismann, R., E. J. Mackie, C. A. Pearson, and T. Sakakura. 1986. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47:131-139.
2. McGowan, S. 1992. Extracellular matrix and the regulation of lung development and repair. FASEB J. 6:2895-2904.
3. Kovacs, E., and L. DiPietro. 1994. Fihrogenic cytokines and connective tissue production. FASKB J. 8:854-861.
4. Raghow, R. 1994. The role of extracellular matrix in post-inflammatory wound healing and fibrosis. FASEB J. 8:823-831.
5. Chiquet-Ehrismann, R. 1990. What distinguishes lenascin from fibronectin? FASEB J. 4:2598-2604.
6. Dean, D. C. 1989. Expression of the fihronectin gene. Am. J. Respir. Cell Mol. Biol. 1:5-10.
7. Ruoslahti, E. 1489. Fibronectin and its receptors. Annu. Rev. Biochem. 57: 375-113.
8. Hynes, R. O. 1981. Fibronectin and its relation to cellular structure and behavior. In Cell Biology of the Extracellular Matrix. Vol. 76. E. Hay, editor. Plenum Press. New York. 181-189.
9. Rennard, S. I., and R. G. Crystal. 1981. Fibronectin in human bronchopulmonary lavage fluid. J. Clin. Invest. 69:113-122.
10. Romberger, D. J., J. D. Beckmann, L. Claassen, R. F. Ertl, and S. I. Rennard. 1992. Modulation of fibronectin production of bovine bronchial epithelial cells by transforming growth factor-beta. Am. J. Respir. Cell Mol. Biol. 7:149-155.
11. Roman, J., E. Crouch, K. Pickles, and J. McDonald. 1989. Regulation of fibronectin biosynthesis by dexamethasone, transforming growth factor-beta and cAMP in human cell lines. J. Cell Biol. 106:2159-2217.
12. Koukoulis, G. K., V. E. Gould, A. Bhattacharyya, J. E. Gould, A. A. Howeedy, and I. Virtanen. 1991. Tenascin in normal, reactive, hyperplastic, and neoplastic tissues. Hum. Pathol. 22:636-643.
13. Young, S., L. Y. Chang, and H. E. Erickson. 1994. Tenascin-C in rat lung: distribution, ontogenity and role in branching morphogenesis. Dev. Biol. 161:615-625.
14. Zhao, Y., and S. L. Young. 1995. Tenascin in rat lung development: in situ localization and cellular sources. Am. J. Physiol. 13:L482-L491.
15. Härkönen, E., I. Virtanen, A. Linnala, L. L. Laitinen, and V. L. Kinnula. 1995. Modulation of fibroneclin and tenascin production in human bronchial epithelial cells by inflammatory cytokines in vitro. Am. J. Respir. Cell Mol. Biol. 13:109-115.
16. Linnala, A., V. Kinnula, L. A. Laitinen, V. Lehto, and I. Virtanen. 1995. Transforming growth factor-β regulates the expression of fibronectin and tenascin in BEAS 2B human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 13:578-585.
17. Lighlner, V. A., J. R. Marks, and S. S. McCachren. 1994. Epithelial cells are an important source of tenascin in normal and malignant human breast tissue. Exp. Cell Res. 210:177-181.
18. Hiraiwa, N., K. Hirokatsu, T. Sakakura, and M. Kusakabe. 1993. Induction of tenascin in cancer cells by interactions with embryonic mesenchyme mediated by a diffusible factor. J. Cell Sci. 104:289-296.
19. Howeedy, A. A., I. Virtanen, L. Laitinen, N. S. Gould, G. K. Kokoulis and V. E. Gould. 1990. Differential distribution of tenascin in the normal, hyperplastic and neoplastic breast. Lab. Invest. 6:798-806.
20. Tiitta, O., T. Wahlström, I. Virtanen, and V. E. Gould. 1993. Tenascin in inflammatory conditions and neoplasms of the urinary bladder. Virchows Arch. B Cell Pathol. 63:283-287.
21. Soini, Y., P. Pääkkö, K. Nuorva, D. Kamel, A. Linnala, I. Virtanen, and V.-P. Lehto. 1993. Tenascin immunoreactivity in lung tumors. Am. J. Clin. Pathol. 100:145-150.
22. Jahkola, T., T. Toivonen, K. Von Smitten, C. Blomqvist, and I. Virtanen. 1997. Expression of tenascin invasion border of early breast cancer correlates with higher risk of distant metastasis. Int. J. Cancer (In press)
23. Jaurand, M. C., J. Bignon, and P. Brochard, editors. 1993. International conference on mesothelial cell and mesothelioma: past, present and future. Eur. Respir. Rev. 3.
24. Garlepp, M. J., and C. C. Leong. 1995. Biological and immunological aspects of malignant mesothelioma. Eur. Respir. J. 8:643-650.
25. Filzpatrick, D. R., D. J. Peroni, and H. Bielefeldt-Ohmann. 1995. The role of growth factors and cytokines in the tumorigenesis and immunobiology of malignant mesothelioma. Am. J. Respir. Cell Mol. Biol. 12:455-460.
26. Ke, Y., R. R. Reddel, B. I. Gerwin, H. K. Reddel, A. N .A. Somers, M. G. McMenamin, M. A. LaVeck, R. A. Stahel, J. F. Lechner, and C. C. Harris. 1989. Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma. Am. J. Pathol. 134:979-991.
27. Pelin-Enlund, K., K. Husgafvel-Pursiainen, L. Tammilehto, M. Klockars, K. Jantunen, B. I. Gerwin, C. C. Harris, T. Tuomi, E. Vanhata, K. Mattson, and K. Linnainmaa. 1990. Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients. Carcinogenesis 11:673-681.
28. Kinnula, V. L., K. Aalto, K. O. Raivio, S. Walles, and K. Linnainmaa. 1994. Cytotoxcity of oxidants and asbestos fibers in cultured human mesothelial cells. Free Radic. Biol. Med. 16:169-176.
29. Kinnula, V. L., K. O. Raivio, A. Ekman, and M. Klockars. 1995. Neutrophil and asbestos fiber-induced cytotoxicity in cultured human mesothelial and bronchial epithelial cells. Free Radic. Biol Med. 18:391-399.
30. Pelin, K., K. Husgafvel-Pursiainen, M. Vallas, E. Vanhala, and K. Linnainmaa. 1992. Cytotoxicity and anaphase aberrations induced by mineral fibers in cultured human mesothelial cells. Toxicology In Vitro 5:445-450.
31. Vartio, T., L. Laitinen, O. Närvänen, M. Cutolo, L.-E. Thornell, L. Zardi. and I. Virtanen. 1987. Differential expression of the ED sequence-containing form of cellular libronectin in embryonic and adult human tissues. J. Cell Sci. 88:419-430.
32. 4 Integrin and newly deposited laminin-1 and laminin-5 form the adhesion mechanism of gastric carcinoma. Am. J. Pathol. 149:781-793,
33. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227:680-685.
34. Towbin, H., T. Stachelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications. Proc. Natl. Aiad. Sci. USA 76:4350-4354.
35. Chomezynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Bio-chem. 162:156-159.
36. Kuwahara, M., M. Kuwahara, K. E. Bijwaard, D. M. Gersten, C. A. Diglio. and E. Kagan. 1991. Mesothelial cells produce a chemoatteactant for lung fibroblasts: role of fibronectin. Am. J. Respir. Cell Mol. Biol. 5:256-264.
37. Kuwahara, M., M. Kuwahara, K. Verma, T. Ando, D. R. Hemenway, and F. Kagan. 1994. Asbestos exposure stimulates pleural mesothelial cells to secrete the fibroblast chemoattractant fihronectin. Am. J. Respir. Cell Mol. Biol. 10:167-176.
38. Lightner, V. A., J .R. Marks, and S. S. McCachren. 1994. Epithelial cells are an important source of tenascin in normal and malignant human breast tissue. Exp. Cell Res. 210:177-184.
39. Kaarteenaho-Wiik, R., T. Tani, R. Sormunen, Y. Soini, I. Virtanen, and P. Pääkkö. 1996. Tenascin immunoreactivity as a prognostic marker in usual interstitial pneumonia. Am. J. Respir. Crit. Care Med. 154:511-518.
40. Wallace, W. A. H., S. F., M. Howie, D. Lamb and D. M. Salter. 1995. Tenascin immunoreactivity in cryptogenic fibrosing alveolitis. J. Pathol. 175: 415-420.
41. Pearson. C. A., D. Pearson, S. Shibahara, J. Hofsteenge, and R. Chiquet-Ehrismann. 1988. Tenascin: cDNA cloning and induction by TGF-β. EMBO J. 10:2677-2981.
42. Rettig, J. W., H. P. Erickson, A. P. Albino, and P. Garin-Chesa. 1994. Induction of human tenascin (Neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways. J. Cell Sci. 107:487-497.
43. Rennard, S. I., M.-C. Jaurand, J. Bignon, O. Kawanami, V. J. Ferrans, J. Davidson, and R. G. Crystal. 1984. Role of pleural mesothelial cells in the production of the submesothelial connective tissue matrix of lung. Am. Rev. Respir. Dis. 130:267-274.
44. Ferriola, P., and W. Stewart. 1996. Fibronectin expression and organization in mesothelial and mesothelioma cells. Am. J. Physiol. 271:L804-L812.
45. Upham, J. W., M. J. Garlepp, A. W. Musk, and B. W. S. Robinson. 1995. Malignant mesothclioma: new insights into tumour biology and immunology as a basis for new treatment approaches. Thorax. 50:887-893.
46. Schwarz, L., J. A. Wright. M.-C. Gingras, P. Kondaiah. D. Danielpour, M. Pimentel, M. H. Sporn, and A. H. Greenberg. 1990. Aberrant TGF-β production and regulation in metastatic malignancy, Growth Factors 3:115-127.
47. Border, W. A., and E. Ruoslahti. 1992. Transforming growth factor in disease: the dark side of tissue repair. J. Clin. Invest. 90:1-7.
48. Roberts, A. B., and M. H. Sporn. 1993. Physiological actions and clinical applications of transforming growth factor. Growth Factors 8:1-9.
49. Maeda, J., N. Ueki, T. Ohkawa, N. Iwahashi, T. Nakano, T. Hada, and K. Higashino. 1994. Transforming growth factor-beta 1-and beta 2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer. Clin. Exp. Immunol. 98:319-322.
50. Klominek, J., K. H. Robert, and K. G. Sundqvist. 1993. Chemotaxis and haptotaxis of human malignant mesothelioma cells: effects of fibronectin, laminin, type IV collagen, and an autocrine motility factor-like substance. Cancer Res. 53:4376-4382.